Ikarian Capital’s Regulus Therapeutics RGLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-105,341
Closed -$217K 111
2022
Q2
$217K Sell
105,341
-23,572
-18% -$48.6K 0.04% 78
2022
Q1
$384K Buy
128,913
+6,071
+5% +$18.1K 0.05% 106
2021
Q4
$388K Hold
122,842
0.06% 110
2021
Q3
$849K Sell
122,842
-1,757
-1% -$12.1K 0.06% 98
2021
Q2
$1.01M Hold
124,599
0.08% 110
2021
Q1
$1.94M Buy
+124,599
New +$1.94M 0.07% 100